EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microbiome signatures associated with clinical stages of gastric Cancer: whole metagenome shotgun sequencing study

Sohyun Jeong, Yi-Tyng Liao, Min-Hsuan Tsai, Yao-Kuang Wang, I-Chen Wu, Chung-Jung Liu, Ming-Shun Wu, Tze-Sian Chan, Ming-Yao Chen, Ping-Jen Hu, Wei-Yu Kao, Hsiang-Chin Liu und 5 weitere

BMC Microbiology · 24.04.2024 · 24 (1)

DOI: 10.1186/s12866-024-03219-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 24.04.2024. Verfasst von Sohyun Jeong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, 1200 Centre Street, Boston, MA, 02131, USA. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastritis, Feces, Metagenome. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer is one of the global health concerns. A series of studies on the stomach have confirmed the role of the microbiome in shaping gastrointestinal diseases. Delineation of microbiome signatures to distinguish chronic gastritis from gastric cancer will provide a non-invasive preventative and treatment strategy. In this study, we performed whole metagenome shotgun sequencing of fecal samples to enhance the detection of rare bacterial species and increase genome sequence coverage. Additionally, we employed multiple bioinformatics approaches to investigate the potential targets of the microbiome as an indicator of differentiating gastric cancer from chronic gastritis.

Results

A total of 65 patients were enrolled, comprising 33 individuals with chronic gastritis and 32 with gastric cancer. Within each group, the chronic gastritis group was sub-grouped into intestinal metaplasia ( n = 15) and non-intestinal metaplasia ( n = 18); the gastric cancer group, early stage (stages 1 and 2, n = 13) and late stage (stages 3 and 4, n = 19) cancer. No significant differences in alpha and beta diversities were detected among the patient groups. However, in a two-group univariate comparison, higher Fusobacteria abundance was identified in phylum; Fusobacteria presented higher abundance in gastric cancer (LDA scored 4.27, q = 0.041 in LEfSe). Age and sex-adjusted MaAsLin and Random Forest variable of importance (VIMP) analysis in species provided meaningful features; Bacteria_caccae was the most contributing species toward gastric cancer and late-stage cancer (beta:2.43, se:0.891, p:0.008 , VIMP score:2.543). In contrast, Bifidobacterium_longum significantly contributed to chronic gastritis (beta:-1.8, se:0.699, p:0.009 , VIMP score:1.988). Age, sex, and BMI-adjusted MasAsLin on metabolic pathway analysis showed that GLCMANNANAUT-PWY degradation was higher in gastric cancer and one of the contributing species was Fusobacterium_varium .

Conclusion

Microbiomes belonging to the pathogenic phylum Fusobacteria and species Bacteroides_caccae and Streptococcus_anginosus can be significant targets for monitoring the progression of gastric cancer. Whereas Bifidobacterium_longum and Lachnospiraceae_bacterium_5_1_63FAA might be protection biomarkers against gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsGastritisFecesMetagenomeBacteriaHumansMaleFemaleMiddle AgedAgedGastrointestinal MicrobiomeAdult

Stichwörter der Autor:innen

Bacteroides_caccaeBifidobacterium_longumFusobacteriaGLCMANNANAUT-PWYLachnospiraceae_bacterium_5_1_63FAAStreptococcus_anginosus

Autor:innen und Institutionen

  • Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, 1200 Centre Street, Boston, MA, 02131, USA.
  • Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Development Center for Biotechnology, Taipei, Taiwan.
  • Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 TzYou 1st Rd, Kaohsiung City, 80756, Taiwan.
  • Department of Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.

Zitieren

APA

Jeong, S., Liao, Y. T., Tsai, M. H., Wang, Y. K., Wu, I. C., Liu, C. J., Wu, M. S., Chan, T. S., Chen, M. Y., Hu, P. J., Kao, W. Y., Liu, H. C., Tsai, M. J., Liu, C. Y., Chang, C. C., Wu, D. C., & Hsu, Y. H. (2024). Microbiome signatures associated with clinical stages of gastric Cancer: whole metagenome shotgun sequencing study. BMC Microbiology, 24(1). https://doi.org/10.1186/s12866-024-03219-2

Vancouver

Jeong S, Liao YT, Tsai MH, Wang YK, Wu IC, Liu CJ, et al. Microbiome signatures associated with clinical stages of gastric Cancer: whole metagenome shotgun sequencing study. BMC Microbiology. 2024;24(1). doi:10.1186/s12866-024-03219-2

BibTeX
@article{Jeong2024,
  author = {Jeong, Sohyun and Liao, Yi-Tyng and Tsai, Min-Hsuan and Wang, Yao-Kuang and Wu, I-Chen and Liu, Chung-Jung and Wu, Ming-Shun and Chan, Tze-Sian and Chen, Ming-Yao and Hu, Ping-Jen and Kao, Wei-Yu and Liu, Hsiang-Chin and Tsai, Ming-Ju and Liu, Cheng-Yuan and Chang, Chun-Chao and Wu, Deng-Chyang and Hsu, Yi-Hsiang},
  title = {Microbiome signatures associated with clinical stages of gastric Cancer: whole metagenome shotgun sequencing study},
  journal = {BMC Microbiology},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12866-024-03219-2}
}
Kostenlos starten →